Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Lancet Neurol. 2017 Jan;16(1):55–65. doi: 10.1016/S1474-4422(16)30291-5

Figure 2. Comparison of motor-dementia interval and survival across Lewy body spectrum patients stratified by neuropathological group.

Figure 2

Box-plots display the range of motor-dementia interval (MDI) for (A) total AD neuropathological change, (B) stages of senile plaque pathology, and (C) Braak stages of neurofibrillary tau. Dashed lines represent across-groups comparison (one-way ANOVA) and solid lines represent post-hoc individual group comparisons (independent t-tests) ***=p<0·001, **=p<0·01, *=p≤0·05. Kaplan-Meier curves depict the proportion of patients surviving at given time points observed for (D) total AD neuropathological change, (E) stages of senile plaque pathology, and (F) Braak stages of neurofibrillary tau. Symbols above reference line denote: † p≤0·05 compared to int.AD, * p<0·05 compared to low AD/CA/BI-II, ‡ p<0·02 compared to pure SYN/C0/B0 (independent sample t-tests).